Stylus Metal 10Pcs Touch BHUS iPad Phone Cell For Plug Anti-Dust & Pen Screen Styluses


  1. Home
  2. Stylus Metal 10Pcs Touch BHUS iPad Phone Cell For Plug Anti-Dust & Pen Screen
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
10Pcs Metal Stylus Touch Screen Pen & Anti-Dust Plug For Cell Phone iPad BHUS
Condition: New: A brand-new, unused, unopened, undamaged item in its original packaging (where packaging is Brand:

Unbranded

Fit for 3: SUMSANG MPN:

Does not apply

Fit for 4: HTC Color:

ten color

Fit for 5: Sony Type: sharp screen touch pen
Material: Plastic Country/Region of Manufacture: China
UPC:

Does not apply

Fit for 1: Iphone
EAN:

Does not apply

Fit for 2: iPad tablet PC
ISBN:

Does not apply








published on tue nov 09 2021

Stylus Metal 10Pcs Touch BHUS iPad Phone Cell For Plug Anti-Dust & Pen Screen Styluses

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

Stylus Metal 10Pcs Touch BHUS iPad Phone Cell For Plug Anti-Dust & Pen Screen Styluses

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS